Cargando…
IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells
BACKGROUND: Interleukin (IL)-11, a cytokine produced by breast cancer, has been implicated in breast cancer-induced osteolysis (bone destruction) but the mechanism(s) of action remain controversial. Some studies show that IL-11 is able to promote osteoclast formation independent of the receptor acti...
Autores principales: | McCoy, Erin M, Hong, Huixian, Pruitt, Hawley C, Feng, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554506/ https://www.ncbi.nlm.nih.gov/pubmed/23311882 http://dx.doi.org/10.1186/1471-2407-13-16 |
Ejemplares similares
-
Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
Publicado: (1995) -
Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis
por: Gorissen, Ben, et al.
Publicado: (2018) -
Osteoclast-Derived Extracellular Vesicles: Novel Regulators of Osteoclastogenesis and Osteoclast–Osteoblasts Communication in Bone Remodeling
por: Yuan, Feng-Lai, et al.
Publicado: (2018) -
Inositol Hexakisphosphate Inhibits Osteoclastogenesis on RAW 264.7 Cells and Human Primary Osteoclasts
por: Arriero, María del Mar, et al.
Publicado: (2012) -
Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations
por: Herbert, Bethany A., et al.
Publicado: (2015)